Welcome to Molecular Oncology Tumor Boards

The Molecular Oncology Tumor Boards are a series of bi-monthly, user-driven discussions designed to help cancer care providers with the interpretation and understanding of tumor molecular profiling tests and studies. Moderated by an expert pathologist and medical oncologist, each case will be updated with new information over a 2-week period as user comments are added. Sign in with your ASCO username and password to participate. After 2 weeks, the discussion will be locked to further commentary and users will be able to claim CME credit for their participation. Visit ASCO University to learn more. 

To participate in discussions on other oncology-related topics, visit ASCO’s member community on myConnection. Connect with colleagues, build your professional network, exchange ideas, collaborate, and more

LOGIN TO START A DISCUSSION
Molecular Oncology Tumor Board
ASCO University
Apr 10, 2019 3:29 PM
Read more to answer the following questions:
What other options are available for genotyping?
Would you begin therapy without genotyping and, if so, what would you recommend?
Molecular Oncology Tumor Board
ASCO University
Feb 06, 2019 1:48 PM
Read more to answer the following questions:
1. How are diffuse large B-cell lymphoma not otherwise specified, high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements, and high-grade B-cell lymphoma not otherwise specified defined by the 2016 revised WHO Classification of Lymphoid...
Molecular Oncology Tumor Board
ASCO University
Dec 05, 2018 10:00 AM
Read more to answer the following questions:
1. What histopathological and/or molecular features, if any, are prognostic for this patient’s diagnosis?
2. What are the optimal testing methods for IDH mutation, MGMT methylation status, and 1p/19q deletional status?
Molecular Oncology Tumor Board
ASCO University
Oct 17, 2018 9:51 AM
Participant Instructions: Welcome to the Molecular Oncology Tumor Board Series! This educational initiative is a collaboration between the American Society of Clinical Oncology (ASCO), College of American Pathologists (CAP), and Association for Molecular Pathology (AMP).
A new case will be...
Molecular Oncology Tumor Board
ASCO University
Aug 08, 2018 7:15 AM
Read more to answer the following questions:
1. Which men with prostate cancer should be referred to genetic counseling for consideration of genetic testing?
2. If we as oncologists are ordering the test ourselves due to the shortage of genetic counselors, which test should we order?  Is testing...

Pages


Advertisement